John A. Baron

67.6k total citations · 12 hit papers
520 papers, 39.8k citations indexed

About

John A. Baron is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, John A. Baron has authored 520 papers receiving a total of 39.8k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Oncology, 129 papers in Surgery and 125 papers in Pathology and Forensic Medicine. Recurrent topics in John A. Baron's work include Colorectal Cancer Screening and Detection (108 papers), Genetic factors in colorectal cancer (80 papers) and Inflammatory mediators and NSAID effects (51 papers). John A. Baron is often cited by papers focused on Colorectal Cancer Screening and Detection (108 papers), Genetic factors in colorectal cancer (80 papers) and Inflammatory mediators and NSAID effects (51 papers). John A. Baron collaborates with scholars based in United States, United Kingdom and Sweden. John A. Baron's co-authors include Robert S. Sandler, Henrik Toft Sørensen, Jane Barrett, E. Robert Greenberg, Elena Losina, Lene Mellemkjær, Jørgen H. Olsen, Jeffrey N. Katz, Robert W. Haile and Robert S. Bresalier and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

John A. Baron

506 papers receiving 38.3k citations

Hit Papers

Cardiovascular Events Ass... 1990 2026 2002 2014 2005 2000 2003 2012 2010 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John A. Baron 12.3k 9.7k 7.2k 5.4k 5.0k 520 39.8k
Robert S. Sandler 8.1k 0.7× 11.5k 1.2× 3.4k 0.5× 4.2k 0.8× 6.0k 1.2× 519 33.2k
Andrew T. Chan 9.4k 0.8× 4.8k 0.5× 4.9k 0.7× 3.7k 0.7× 4.6k 0.9× 610 31.0k
Eva Negri 18.8k 1.5× 9.6k 1.0× 7.4k 1.0× 9.8k 1.8× 4.9k 1.0× 1.1k 58.0k
Hans‐Olov Adami 16.8k 1.4× 8.8k 0.9× 5.5k 0.8× 9.6k 1.8× 7.3k 1.5× 663 48.1k
Aaron R. Folsom 6.4k 0.5× 11.1k 1.2× 4.0k 0.6× 8.4k 1.6× 5.9k 1.2× 867 75.6k
Peter Boyle 13.9k 1.1× 5.6k 0.6× 3.6k 0.5× 8.6k 1.6× 4.2k 0.9× 635 43.8k
Alicja Wolk 8.4k 0.7× 4.8k 0.5× 4.7k 0.7× 3.5k 0.6× 3.2k 0.7× 576 40.9k
William J. Blot 5.9k 0.5× 11.0k 1.1× 2.8k 0.4× 8.4k 1.6× 2.0k 0.4× 532 33.0k
Rory Collins 3.6k 0.3× 15.0k 1.6× 3.3k 0.5× 4.6k 0.8× 4.9k 1.0× 245 62.1k
Julie E. Buring 3.5k 0.3× 10.9k 1.1× 6.3k 0.9× 4.0k 0.7× 4.4k 0.9× 602 66.5k

Countries citing papers authored by John A. Baron

Since Specialization
Citations

This map shows the geographic impact of John A. Baron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Baron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Baron more than expected).

Fields of papers citing papers by John A. Baron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Baron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Baron. The network helps show where John A. Baron may publish in the future.

Co-authorship network of co-authors of John A. Baron

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Baron. A scholar is included among the top collaborators of John A. Baron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Baron. John A. Baron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Titova, Olga E., Carl Brunius, Eva Warensjö Lemming, et al.. (2023). Comprehensive analyses of circulating cardiometabolic proteins and objective measures of fat mass. International Journal of Obesity. 47(11). 1043–1049. 2 indexed citations
2.
Barry, Elizabeth L., Veronika Fedirko, Ken Liu, et al.. (2022). Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas. Cancer Prevention Research. 15(8). 521–531. 5 indexed citations
3.
Passarelli, Michael N., Bonne M. Thompson, Jeffrey G. McDonald, et al.. (2021). Circulating 27-hydroxycholesterol and Risk of Colorectal Adenomas and Serrated Polyps. Cancer Prevention Research. 14(4). 479–488. 9 indexed citations
4.
Zheng, Yingye, Xinwei Hua, Aung Ko Win, et al.. (2020). A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors. Cancer Epidemiology Biomarkers & Prevention. 29(3). 549–557. 25 indexed citations
5.
Barry, Elizabeth L., Veronika Fedirko, Karan Uppal, et al.. (2020). Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk. Cancer Prevention Research. 13(10). 863–876. 5 indexed citations
6.
Calderwood, Audrey H., John A. Baron, Leila A. Mott, et al.. (2019). No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial. Cancer Prevention Research. 12(5). 295–304. 25 indexed citations
7.
Hodge, Rebecca D., Hannah Mandle, Stephen Ray, et al.. (2018). Effects of Supplemental Calcium and Vitamin D on Expression of Toll-Like Receptors and Phospho-IKKα/β in the Normal Rectal Mucosa of Colorectal Adenoma Patients. Cancer Prevention Research. 11(11). 707–716. 1 indexed citations
8.
Rees, Judy R., Carolyn Morris, Janet L. Peacock, et al.. (2017). Unmetabolized Folic Acid, Tetrahydrofolate, and Colorectal Adenoma Risk. Cancer Prevention Research. 10(8). 451–458. 13 indexed citations
9.
Gupta, Samir, Elizabeth T. Jacobs, John A. Baron, et al.. (2015). Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. Gut. 66(3). 446–453. 32 indexed citations
10.
Onega, Tracy, John A. Baron, Søren Paaske Johnsen, et al.. (2015). Cancer Risk and Subsequent Survival after Hospitalization for Intermittent Claudication. Cancer Epidemiology Biomarkers & Prevention. 24(4). 744–748. 9 indexed citations
11.
Fedirko, Veronika, Patrick T. Bradshaw, Jane C. Figueiredo, et al.. (2015). Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prevention Research. 8(11). 1061–1068. 105 indexed citations
12.
Crockett, Seth D., Leila A. Mott, Elizabeth L. Barry, et al.. (2014). C-reactive Protein and Risk of Colorectal Adenomas or Serrated Polyps: A Prospective Study. Cancer Prevention Research. 7(11). 1122–1127. 10 indexed citations
13.
Erichsen, Rune, Claus Sværke, Henrik Toft Sørensen, Robert S. Sandler, & John A. Baron. (2013). Risk of Colorectal Cancer in Patients with Acute Myocardial Infarction and Stroke: A Nationwide Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 22(11). 1994–1999. 27 indexed citations
14.
Newcomb, Polly A., Ellen Kampman, Amy Trentham‐Dietz, et al.. (2013). Alcohol Consumption Before and After Breast Cancer Diagnosis: Associations With Survival From Breast Cancer, Cardiovascular Disease, and Other Causes. Journal of Clinical Oncology. 31(16). 1939–1946. 48 indexed citations
15.
Yurgelun, Matthew B., Ajay Goel, Jason L. Hornick, et al.. (2012). Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps. Cancer Prevention Research. 5(4). 574–582. 83 indexed citations
16.
Phipps, Amanda I., Daniel D. Buchanan, Karen W. Makar, et al.. (2012). BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1792–1798. 97 indexed citations
17.
Figueiredo, Jane C., Won Lee, David V. Conti, et al.. (2010). A Candidate Gene Study of Folate-Associated One Carbon Metabolism Genes and Colorectal Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 19(7). 1812–1821. 32 indexed citations
18.
Wallace, Kristin, Maria V. Grau, A. Joan Levine, et al.. (2010). Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa. Cancer Prevention Research. 3(12). 1552–1564. 88 indexed citations
19.
Baron, John A.. (2010). Statins and the Colorectum: Hope for Chemoprevention?. Cancer Prevention Research. 3(5). 573–575. 11 indexed citations
20.
Poynter, Jenny N., Elizabeth T. Jacobs, Jane C. Figueiredo, et al.. (2010). Genetic Variation in the Vitamin D Receptor ( VDR ) and the Vitamin D–Binding Protein ( GC ) and Risk for Colorectal Cancer: Results from the Colon Cancer Family Registry. Cancer Epidemiology Biomarkers & Prevention. 19(2). 525–536. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026